Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reveal a moderate level of engagement, with comments referencing the plateau effect at 7.5% concentrations and mentioning that higher concentrations might not offer added benefits, as seen in phrases like 'higher concentrations may not be more effective' and questions about FDA approval, indicating curiosity and contemplation about clinical practice implications.
Most discussions acknowledge the findings that increasing minoxidil beyond 5% does not significantly improve outcomes, showing general agreement with the research.
Participants are moderately interested, reflected by queries about FDA approval and efficacy, indicating curiosity but not highly passionate responses.
The discussions involve some level of engagement through questions and references to scientific considerations, but lack in-depth analysis or debate.
The overall impact appears limited as conversations mostly revolve around clarifications and implications rather than transformative insights or calls for change.
高濃度ミノキシジルの効果については、結果がわかれていて、まだ検証の余地がありそうですね ①ミノキシジル5%＜15% ②ミノキシジル10%＞5% AGAガイドラインではミノキシジル2%<5%は認められていますが、5%以上はずっと右肩上がりというより、どこかで天井がありそうですね https://t.co/A5WXUay9WN https://t.co/13gsmZdkvD
参考文献 https://t.co/oVLRyCXUdN
Importantly, higher concentrations of topical minoxidil may not be more effective, with a plateau reaching at 7.5% concentrations (especially in PEG formulations), according to a recent paper in @ced_wiley https://t.co/bno8sP4IhJ 6/11
Which of the following is the US Food and Drug Administration (FDA)-approved indication for use of topical minoxidil? a) Alopecia areata. b) Androgenetic alopecia. c) Frontal fibrosing alopecia. d) Monilethrix. e) Chronic telogen effluvium. https://t.co/v5FmJULMY0
This video explores whether higher-than-5% concentrations of topical minoxidil offer additional benefits for androgenetic alopecia, based on scientific studies, clinical trials, and safety data.
This video examines Bryan Johnson's hair loss prevention protocol, exploring the safety and potential effectiveness of low-level laser therapy using red light lasers and LEDs for hair growth in men with androgenic…
参考文献 https://t.co/oVLRyCXUdN
高濃度ミノキシジルの効果については、結果がわかれていて、まだ検証の余地がありそうですね ①ミノキシジル5%＜15% ②ミノキシジル10%＞5% AGAガイドラインではミノキシジル2%<5%は認められていますが、5%以上はずっと右肩上がりというより、どこかで天井がありそうですね https://t.co/A5WXUay9WN https://t.co/13gsmZdkvD
Which of the following is the US Food and Drug Administration (FDA)-approved indication for use of topical minoxidil? a) Alopecia areata. b) Androgenetic alopecia. c) Frontal fibrosing alopecia. d) Monilethrix. e) Chronic telogen effluvium. https://t.co/v5FmJULMY0
Importantly, higher concentrations of topical minoxidil may not be more effective, with a plateau reaching at 7.5% concentrations (especially in PEG formulations), according to a recent paper in @ced_wiley https://t.co/bno8sP4IhJ 6/11